Trials / Terminated
TerminatedNCT03727009
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 409 (actual)
- Sponsor
- Exact Sciences Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Detailed description
Subjects will have been recently diagnosed with an untreated hematologic malignancy. Subjects will have a blood sample collected at enrollment and provide medical history prior to initiation of treatment. There will be no further follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood Sample Collection | Subjects participating in the study will have blood drawn at enrollment. |
Timeline
- Start date
- 2018-12-07
- Primary completion
- 2020-03-24
- Completion
- 2020-03-24
- First posted
- 2018-11-01
- Last updated
- 2021-02-03
Locations
35 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03727009. Inclusion in this directory is not an endorsement.